Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of...
42 insider purchases on record · latest filing 2025-05-19.
Insiders have also filed 82 sale transactions at TARA.